Skip to main content
Figure 1 | Cell & Bioscience

Figure 1

From: Purified anti-CD3 × anti-HER2 bispecific antibody potentiates cytokine-induced killer cells of poor spontaneous cytotoxicity against breast cancer cells

Figure 1

Chemical crosslinking of anti-CD3 and anti- HER2. (A) Native electrophoresis of crosslinker-conjugated IgG monomer. Input represents unconjugated control. 10 μg protein per lane. (B) Native electrophoresis of crosslinked anti-CD3 × anti-HER2 with combinations of crosslinkers. 10 μg protein per lane. (C) Native electrophoresis of Traut’s-SMCC-crosslinked anti-CD3 × anti-HER2 following storage under various conditions for 3 months (r. t, room temperature). 10 μg protein per lane.

Back to article page